Published in Thromb Res on June 09, 2016
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet (2013) 5.43
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet (2009) 2.37
Chronic vascular catheterization in the rat: comparison of three techniques. Physiol Behav (1984) 1.76
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost (2013) 1.21
Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology (2012) 1.13
Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study. Br J Haematol (2003) 1.09
Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artif Organs (2005) 1.06
Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis. Circulation (2015) 1.02
Techniques for the chronic cannulation of the jugular vein in mice. Pharmacol Biochem Behav (1979) 1.00
mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite. Am J Physiol Renal Physiol (2010) 1.00
A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int (2001) 0.97
Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood (2002) 0.97
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. J Vasc Access (2006) 0.90
Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban. Mediators Inflamm (2011) 0.89
Chronic vascular catheterization in the mouse. Physiol Behav (1993) 0.88
Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst Rev (2011) 0.87
Dose-finding study of rivaroxaban in hemodialysis patients. Am J Kidney Dis (2015) 0.85
Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med (2013) 0.85
Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke. J Cereb Blood Flow Metab (2013) 0.85
Comparison of novel oral anticoagulants versus vitamin K antagonists in patients with chronic kidney disease. Curr Opin Nephrol Hypertens (2015) 0.84
Double-vein jugular/inferior vena cava clamp technique for long-term in vivo studies in rats. Physiol Behav (1998) 0.84
Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis (2015) 0.83
Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial. Clin J Am Soc Nephrol (2011) 0.83
Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transplant (2013) 0.81
Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Cancer Chemother Pharmacol (2013) 0.81
Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Thromb Haemost (2012) 0.80
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment. Thromb J (2014) 0.79
Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums. World J Crit Care Med (2015) 0.78
Minimally Invasive Monitoring of Chronic Central Venous Catheter Patency in Mice Using Digital Subtraction Angiography (DSA). PLoS One (2015) 0.78
Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism. Thromb Haemost (2015) 0.77